All News

HLA-B%2A2705.png

Worse Outcomes in HLA-B27+ JIA

d MedPage Today

Patients with juvenile idiopathic arthritis (JIA) who carried the HLA-B27 genetic marker tended to have worse long-term outcomes, including lower rates of drug-free remission, in a prospective Scandinavian study.

Read Article
morbidity,covid,heart,lung,brain

Predicting Premature Death with Multimorbidity

d Jack Cush, MD

Machine learning (ML) models were used to predict premature death in inflammatory bowel disease (IBD) patients with multimorbidity, the co-occurrence of 2 or more chronic conditions. 

Read Article
JAK Janus

Treating chronic inflammatory diseases with JAK inhibitors

d Science Daily

Janus kinase inhibitors (JAKis) are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease or ulcerative colitis.

Read Article
hip.fracture.jpg

Peripheral Nerve Blocks for Hip Fractures

d Jack Cush, MD

JAMA reviews the use of peripheral nerve block with hip fractures as an effective pain management strategy that can be performed by credentialed clinicians outside of the operating room.

Read Article
Medical.costs.RMD

Autoimmune Disease Impact Report

d Jack Cush, MD

Integrated Benefit Institute, a nonprofit independent research organization, has published its 2025 Autoimmune Disease Impact Report, which examines the health and productivity impacts of five prevalent and costly autoimmune conditions: rheumatoid arthritis, multiple sclerosis, inflammat

Read Article
ACPA specificity and recognition motifs examined in 6,907 patients with RA from 5 Scandinavian cohorts. ACPA targeting non-glycine citrulline motifs assoc. more strongly w/ HLA-SE; ACPA to glycine citrulline motifs assoc. w/ smoking and IgA ACPA A&R https://t.co/PmKv3dZLc4 https://t.co/NdPG4Orfj4

Links:

ACR_Journals ACR_Journals ( View Tweet)
Autoimmune Disease Impact Report Integrated Benefit Institute, a nonprofit independent research organization, has published its 2025 Autoimmune Disease Impact Report, which examines the health and productivity impacts of five prevalent and costly autoimmune conditions: https://t.co/TfXZti5NN3
Dr. John Cush RheumNow ( View Tweet)
2024 Rheumatology Year in Review 2024 was a year of surprising new growth in technology, with the expansion of new therapeutic options for many patients and clinicians. https://t.co/JjG8oYTkKQ https://t.co/YgHMMiAQ9Z

Links:

Dr. John Cush RheumNow ( View Tweet)
The British Society for Rheumatology (BSR) guidelines 2024 for the management of Sjogren’s Syndrome. Summary slide of key recommendations. https://t.co/qBuCFM8MnX https://t.co/DYgGzAgISa

Links:

Antoni Chan MD (Prof) synovialjoints ( View Tweet)
Dr. Swamy Venuturupalli, a Community Practice Innovation Award recipient, is transforming telehealth in rheumatology! His project introduces an innovative app that empowers patients to examine their own joints—making high-quality telehealth a seamless part of care. https://t.co/R5M4jtVz5m

Links:

Rheumatology Research Foundation RheumResearch ( View Tweet)
#Thrombocytopenia is common in #antiphospholipid syndrome (APS), and is likely associated with more severe disease. Although the pathophysiology underlying thrombocytopenia in APS has yet to be definitively revealed, mechanisms that play a role (at least in subsets of patients) https://t.co/pUXmb1irbw

Links:

Alberto Giraldo alb_giraldo ( View Tweet)
THERE’S STILL TIME to join us for #SOTA25, April 4-6 in Chicago! Secure your seat TODAY for a weekend of #rheum education, connection, & innovation → https://t.co/DEmGVZO5Af https://t.co/1D2j2enA2X

Links:

American College of Rheumatology ACRheum ( View Tweet)
Of >105,000 participants with 30-year follow-up, only 9.3% achieved healthy aging (age 70, w/o any chronic diseases). Their diet was significantly associated with this outcome🧵 @NatureMedicine https://t.co/VHxmdLvoDe

Links:

Eric Topol EricTopol ( View Tweet)
• Don't be afraid of being different. • Take risks. • Be curious. • Don't be afraid to fail. • Work hard for the things you love the most. https://t.co/7OeB5WfnNy

Links:

Prof. Feynman ProfFeynman ( View Tweet)
Congratulation to all the MSIVs who matched last week - Looking forward to ya'll becoming RHEUMATOLOGISTs of the futre https://t.co/NAePO72j9Z
Dr. John Cush RheumNow ( View Tweet)
Disease activity during Pregnancy in Rheumatoid arthritis and Spondyloarthritis A prospective French study of rheumatoid arthritis (RA) or spondyloarthritis (SpA) patients showed that most maintained stable disease activity during pregnancy, but over one-third flared and https://t.co/3k6ZJTybAb
Dr. John Cush RheumNow ( View Tweet)
Increasing Prevalence of Osteoporosis Research published in Osteoporosis International studied NHANES data showed increasing trends in osteoporosis in the United States of America. https://t.co/9Ic2e6kaFR https://t.co/tVmFAp7EVe

Links:

Dr. John Cush RheumNow ( View Tweet)
Full read Overview of the effects of Menopause and Estrogen on autoimmune disorders https://t.co/NpVPrnPT6x https://t.co/wt9f5D7WXL

Links:

Dr. John Cush RheumNow ( View Tweet)
Post hoc analysis of 5 ph III Belimumab RCTs (BLISS, etc, N=3086) on skin outcomes BILAG & SLEDAI-2K), BEL was superior to PBO (mcBILAG OR: 1.29; mcSLEDAI-2K OR: 1.37). Also if SLEDAI ≥10 & dsDNA+ pts. BEL prevented skin flares (HR 0.70) https://t.co/p1MVVf97Go https://t.co/qwWUyegpyi

Links:

Dr. John Cush RheumNow ( View Tweet)
55 myositis (IIM) pts studied Nailfold Capillaries, MSAbs, cytokines & IFN genes. MDA5(+) pts signif more dilated (DIL), giant & abnl morphology caps, w/ microhemorrhages (MH) vs ARS (+) pts. MH & DIL assoc w/ MX1, IFI27, IP-10, RANTES, GROα. Giant caps assoc w/ IFI27, SDF-1α, https://t.co/3WQL8Sw0rq
Dr. John Cush RheumNow ( View Tweet)
×